Literature DB >> 10931160

Different regulation of factor H and FHL-1/reconectin by inflammatory mediators and expression of the two proteins in rheumatoid arthritis (RA).

M A Friese1, J Hellwage, T S Jokiranta, S Meri, H J Müller-Quernheim, H H Peter, H Eibel, P F Zipfel.   

Abstract

Factor H and the FHL-1/reconectin protein are two human plasma proteins that act as important regulators of the alternative complement pathway. Each protein is encoded by a unique transcript, but both mRNAs are derived from the factor H gene by means of alternative processing. In order to address potential functional differences between the two proteins we analysed their expression in hepatic and non-hepatic cells and studied their regulation by inflammatory mediators. We demonstrate that factor H and FHL-1/reconectin transcripts which are regulated by the same gene promoter and are initiated at the same transcription start site are differently expressed. Expression of the molecules is induced and regulated by the inflammatory mediators interferon-gamma (IFN-gamma) and the anti-inflammatory glucocorticoid dexamethasone. Both factor H and FHL-1/reconectin are expressed and secreted by synovial fibroblasts and are present in synovial fluid derived from patients suffering from rheumatoid or reactive arthritis. The local synthesis in synovial fibroblasts and their induction by IFN-gamma and dexamethasone, but not by tumour necrosis factor-alpha, suggests for each of the two complement regulators a protective role in RA.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10931160      PMCID: PMC1905714          DOI: 10.1046/j.1365-2249.2000.01285.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  39 in total

1.  Solution structure of the fifth repeat of factor H: a second example of the complement control protein module.

Authors:  P N Barlow; D G Norman; A Steinkasserer; T J Horne; J Pearce; P C Driscoll; R B Sim; I D Campbell
Journal:  Biochemistry       Date:  1992-04-14       Impact factor: 3.162

2.  Biosynthesis of complement factor H by human umbilical vein endothelial cells. Regulation by T cell growth factor and IFN-gamma.

Authors:  R A Brooimans; P S Hiemstra; A A van der Ark; R B Sim; L A van Es; M R Daha
Journal:  J Immunol       Date:  1989-03-15       Impact factor: 5.422

3.  Synovial fluid levels of complement SC5b-9 and fragment Bb are elevated in patients with rheumatoid arthritis.

Authors:  J P Brodeur; S Ruddy; L B Schwartz; G Moxley
Journal:  Arthritis Rheum       Date:  1991-12

Review 4.  Genetics and deficiencies of the soluble regulatory proteins of the complement system.

Authors:  R B Sim; K Kölble; M A McAleer; O Dominguez; V M Dee
Journal:  Int Rev Immunol       Date:  1993       Impact factor: 5.311

5.  Interferon-induced transcriptional and post-transcriptional modulation of factor H and C4 binding-protein synthesis in human monocytes.

Authors:  D F Lappin; K Whaley
Journal:  Biochem J       Date:  1990-11-01       Impact factor: 3.857

6.  Solution structure of a pair of complement modules by nuclear magnetic resonance.

Authors:  P N Barlow; A Steinkasserer; D G Norman; B Kieffer; A P Wiles; R B Sim; I D Campbell
Journal:  J Mol Biol       Date:  1993-07-05       Impact factor: 5.469

7.  Expression of the components and regulatory proteins of the alternative complement pathway and the membrane attack complex in normal and diseased synovium.

Authors:  D Guc; P Gulati; C Lemercier; D Lappin; G D Birnie; K Whaley
Journal:  Rheumatol Int       Date:  1993       Impact factor: 2.631

8.  Terminal complement complex in synovial tissue from patients affected by rheumatoid arthritis, osteoarthritis and acute joint trauma.

Authors:  A Corvetta; G Pomponio; N Rinaldi; M M Luchetti; C Di Loreto; D Stramazzotti
Journal:  Clin Exp Rheumatol       Date:  1992 Sep-Oct       Impact factor: 4.473

9.  Human complement factor H. Tissue specificity in the expression of three different mRNA species.

Authors:  W Schwaeble; H Schwaiger; R A Brooimans; A Barbieri; J Möst; M Hirsch-Kauffmann; M Tiefenthaler; D F Lappin; M R Daha; K Whaley
Journal:  Eur J Biochem       Date:  1991-06-01

10.  Measurement of terminal complement complexes in rheumatoid arthritis.

Authors:  B P Morgan; R H Daniels; B D Williams
Journal:  Clin Exp Immunol       Date:  1988-09       Impact factor: 4.330

View more
  23 in total

1.  Novel approach to prevent the transition from the hyperdynamic phase to the hypodynamic phase of sepsis: role of adrenomedullin and adrenomedullin binding protein-1.

Authors:  Shaolong Yang; Mian Zhou; Irshad H Chaudry; Ping Wang
Journal:  Ann Surg       Date:  2002-11       Impact factor: 12.969

2.  The C-terminus of complement factor H is essential for host cell protection.

Authors:  Mihály Józsi; Martin Oppermann; John D Lambris; Peter F Zipfel
Journal:  Mol Immunol       Date:  2007-01-17       Impact factor: 4.407

3.  Essential role of surface-bound complement factor H in controlling immune complex-induced arthritis.

Authors:  Nirmal K Banda; Gaurav Mehta; Viviana P Ferreira; Claudio Cortes; Matthew C Pickering; Michael K Pangburn; William P Arend; V Michael Holers
Journal:  J Immunol       Date:  2013-02-22       Impact factor: 5.422

Review 4.  The properdin pathway: an "alternative activation pathway" or a "critical amplification loop" for C3 and C5 activation?

Authors:  Richard A Harrison
Journal:  Semin Immunopathol       Date:  2017-11-22       Impact factor: 9.623

5.  Mechanisms responsible for vascular hyporesponsiveness to adrenomedullin after hemorrhage: the central role of adrenomedullin binding protein-1.

Authors:  Rongqian Wu; Xiaoxuan Cui; Weifeng Dong; Mian Zhou; H Hank Simms; Ping Wang
Journal:  Ann Surg       Date:  2005-07       Impact factor: 12.969

6.  The effect of dexamethasone on human mucin 1 expression and antibody-dependent complement sensitivity in a prostate cancer cell line in vitro and in vivo.

Authors:  Masaki Imai; Hee-Young Hwang; James S Norris; Stephen Tomlinson
Journal:  Immunology       Date:  2004-03       Impact factor: 7.397

7.  Release of endogenous anti-inflammatory complement regulators FHL-1 and factor H protects synovial fibroblasts during rheumatoid arthritis.

Authors:  M A Friese; T Manuelian; S Junnikkala; J Hellwage; S Meri; H H Peter; D L Gordon; H Eibel; P F Zipfel
Journal:  Clin Exp Immunol       Date:  2003-06       Impact factor: 4.330

8.  Haemolytic uraemic syndrome and mutations of the factor H gene: a registry-based study of German speaking countries.

Authors:  H P H Neumann; M Salzmann; B Bohnert-Iwan; T Mannuelian; C Skerka; D Lenk; B U Bender; M Cybulla; P Riegler; A Königsrainer; U Neyer; A Bock; U Widmer; D A Male; G Franke; P F Zipfel
Journal:  J Med Genet       Date:  2003-09       Impact factor: 6.318

9.  Human vasoactive hormone adrenomedullin and its binding protein rescue experimental animals from shock.

Authors:  Rongqian Wu; Weifeng Dong; Xiaoling Qiang; Youxin Ji; Tianpen Cui; Juntao Yang; Mian Zhou; Steven Blau; Corrado P Marini; Thanjavur S Ravikumar; Ping Wang
Journal:  Peptides       Date:  2008-03-08       Impact factor: 3.750

10.  Comparative Analysis of Novel Complement-Targeted Inhibitors, MiniFH, and the Natural Regulators Factor H and Factor H-like Protein 1 Reveal Functional Determinants of Complement Regulation.

Authors:  Markus J Harder; Markus Anliker; Britta Höchsmann; Thomas Simmet; Markus Huber-Lang; Hubert Schrezenmeier; Daniel Ricklin; John D Lambris; Paul N Barlow; Christoph Q Schmidt
Journal:  J Immunol       Date:  2015-12-07       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.